Trajenta 5 mg film-coated tablets

DRUG2 trials

Sponsors

F. Hoffmann-La Roche AG, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA

Conditions

Metastatic non-small cell lung cancer (NSCLC)Type 2 Diabetes Mellitus

Phase 1

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Non-Small Cell Lung Cancer (Morpheus-Lung)

CompletedCTIS2023-504038-23-00

F. Hoffmann-La Roche AGMetastatic non-small cell lung cancer (NSCLC)

Start: 2018-05-10End: 2025-04-02Target: 149Updated: 2025-02-14

Phase 4

Open-label, double-arm, controlled, randomized, multicentre clinical trial to evaluate the impact of pharmacogenetic-guided treatment in patients with insufficiently controlled type 2 diabetes

Active, not recruitingCTIS2025-520686-46-00

Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVAType 2 Diabetes Mellitus

Start: 2025-05-15Target: 504Updated: 2025-09-15